Market
Market
The latest in market for medical-aesthetics practice owners.
Market Semaglutide Face: Why Medspas Are Capitalizing on the GLP-1 Filler Opportunity
As GLP-1 users lose facial volume, medspas are positioning dermal fillers as the aesthetic solution—and the revenue driver.
Market Offering GLP-1 Weight Loss at a Medspa: What Owners Need to Know
GLP-1 services are a high-demand revenue stream, but medspa owners must navigate strict sourcing, prescribing, and compliance rules.
Market Aesthetic Industry Giants Confirm 'Semaglutide Face' as Real Side Effect — GLP-1 Weight Loss Drugs Driving New Patient Demand
Facial fat loss from weight-loss medications is creating a new patient segment seeking volume restoration.